NCT04461509 2026-03-25
High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy
Cedars-Sinai Medical Center
Phase 2 Completed
Clinical Trials
25 trialsNCT03232411 2025-12-04
Biobank for African American Prostate Cancer Research in Florida
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT00853710 2025-11-20
Test Semiquantitative Prostate Specific Antigen (PSA)
Institut Curie
Phase NA Completed
NCT03344757 2025-09-11
Health Gatherings - For Your Health After Cancer
University of Miami
Phase NA Completed
NCT05902637 2025-02-25
MAPROSTATE
Marmara University
Phase NA Completed
NCT00946881 2024-02-07
Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer
Steba Biotech S.A.
Phase 1/2 Completed
NCT05803096 2024-01-30
Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain
Beth Israel Deaconess Medical Center
Phase 4 Completed
NCT02578797 2023-11-09
A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study
Aragon Pharmaceuticals, Inc.
Phase 1 Completed
NCT05834270 2023-04-28
Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH
Menoufia University
Phase NA Completed
NCT05399940 2022-06-01
The Relationship Between Serum PSA Levels and WBC, Delta Neutrophil Index (DNI) and Other Hematological Parameters
Hisar Intercontinental Hospital
Completed
NCT00210249 2022-02-04
PHRC2003
Institut Bergonié
Completed
NCT03938376 2021-04-01
Micro-Ultrasound/Magnetic Resonance Imaging 001
University Health Network, Toronto
Completed
NCT03490032 2020-11-17
PROfind
Advanced Accelerator Applications
Phase 1/2 Completed
NCT03847753 2020-05-22
COMO-GMC
University of Aarhus
Completed
NCT03077659 2019-08-20
Trial of NanoPac® Focal Therapy in Subjects With Prostate Cancer
NanOlogy, LLC
Phase 2 Completed
NCT01310894 2019-07-11
PCM301
Steba Biotech S.A.
Phase 3 Completed
NCT03104907 2018-11-29
Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer
Rigshospitalet, Denmark
Phase NA Completed
NCT01316458 2017-06-01
Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy
Novartis
Phase 2 Completed
NCT01431391 2017-05-30
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Dendreon
Phase 2 Completed
NCT00707356 2016-04-19
Study of WST11 in Patients With Localized Prostate Cancer
Steba Biotech S.A.
Phase 2 Completed
NCT01875393 2016-04-19
PCM304
Steba Biotech S.A.
Phase 3 Completed
NCT01307852 2016-04-06
In Vivo Dosimetry During Prostate Cancer Radiotherapy
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00975429 2015-04-28
Study Using WST11 in Patients With Localized Prostate Cancer
Steba Biotech S.A.
Phase 2 Completed
NCT00753415 2015-03-17
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT00749502 2013-07-25
A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)
Tesaro, Inc.
Phase 1 Completed